No Association Between Outcomes And Anti-Factor Xa Levels For Heparin Monitoring In Patients With Cerebral Venous Thrombosis

被引：0
|
作者：
Pirahanchi, Yasaman
Salottolo, Kristin
Burrell, Christian
DiSalvo, Lauren
Tang, Xu
Bar-Or, David
Bartt, Russell
机构：
来源：
STROKE | 2023年 / 54卷
关键词：
D O I：
10.1161/str.54.suppl_1.TP12
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
ATP12
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Activated Partial Thromboplastin Time versus Anti-Factor Xa Levels for Monitoring Unfractionated Heparin Therapy in Children: An Institutional Experience
    Woods, Gary M.
    Stanek, Joseph
    Harrison, Sheilah
    Texter, Karen
    Kerlin, Bryce A.
    Dunn, Amy L.
    Kumar, Riten
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (07) : 576 - +
  • [32] The anti-factor Xa range for low molecular weight heparin thromboprophylaxis
    Wei, Matthew Y.
    Ward, Salena M.
    HEMATOLOGY REPORTS, 2015, 7 (04) : 80 - 83
  • [33] Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
    Lawlor, Matthew
    Gupta, Aakriti
    Ranard, Lauren S.
    Madhavan, Mahesh V.
    Li, Jianhua
    Eisenberger, Andrew
    Parikh, Sahil A.
    Sethi, Sanjum S.
    Masoumi, Amirali
    THROMBOSIS RESEARCH, 2021, 198 : 79 - 82
  • [34] HEPARIN AND LOW-MOLECULAR WEIGHT HEPARIN - IS ANTI-FACTOR XA ACTIVITY IMPORTANT
    LANE, DA
    RYAN, K
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1989, 114 (04): : 331 - 333
  • [35] Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma
    Karcutskie, Charles A.
    Dharmaraja, Arjuna
    Patel, Jaimin
    Eidelson, Sarah A.
    Padiadpu, Anish B.
    Martin, Arch G.
    Lama, Gabriel
    Lineen, Edward B.
    Namias, Nicholas
    Schulman, Carl I.
    Proctor, Kenneth G.
    JAMA SURGERY, 2018, 153 (02) : 144 - 149
  • [36] Anti-Factor Xa and Activated Partial Thromboplastin Time Measurements for Heparin Monitoring in Mechanical Circulatory Support
    Adatya, Sirtaz
    Uriel, Nir
    Yarmohammadi, Hirad
    Holley, Christopher T.
    Feng, Amy
    Roy, Samit S.
    Reding, Mark T.
    John, Ranjit
    Eckman, Peter
    Zantek, Nicole D.
    JACC-HEART FAILURE, 2015, 3 (04) : 314 - 322
  • [37] Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis
    Fox, Nathan S.
    Laughon, S. Katherine
    Bender, Samuel D.
    Saltzman, Daniel H.
    Rebarber, Andrei
    OBSTETRICS AND GYNECOLOGY, 2008, 112 (04): : 884 - 889
  • [38] Anti-factor Xa Levels Versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin in Patients with Continuous Flow Left Ventricular Assist Devices
    Yarmohammadi, H.
    Holley, C.
    Thennapin, T.
    Duval, S.
    Pritzker, M.
    Cogswell, R.
    John, R.
    Colvin-Adams, M.
    Eckman, P.
    Adatya, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S23 - S24
  • [39] Utility of anti-factor Xa levels in pregnant women receiving low molecular weight heparin prophylaxis
    Allred, Emily
    Quinn, Kristen
    Thorsen, Julia
    Pradarelli, Jason
    Baker, Lisa
    Szabo, Aniko
    Zhao, Shi
    Wassenaar, Timothy
    Kuhlman, Randall
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S280 - S280
  • [40] LACK OF STANDARDIZATION OF THE ANTI-FACTOR (F)XA ACTIVITY REAGENTS USED IN MONITORING TREATMENTS WITH UNFRACTIONATED HEPARIN
    Toulon, Pierre
    Smahi, Motalib
    van Essen-Hollestelle, Martine
    De Pooter, Neila
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 175 - 175
12345